• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Clintec given Queen’s Award for Enterprise International Trade category for second time

Clintec given Queen’s Award for Enterprise International Trade category for second time

May 9, 2017
CenterWatch Staff

Clintec, a global CRO, has been awarded the Queen¹s Award for Enterprise 2017 in the category of International Trade for a second time.

The Queen’s Award, the highest accolade that can be granted to any business operating within the U.K., recognizes outstanding corporate achievement.

Clintec was selected from amongst some of the top performing UK businesses for its differentiated geographical capability and impressive growth in the mid-market of the contract research sector.

Clintec launched into the clinical research sector 20 years ago and has organically developed a broad, diverse and cohesive geographical footprint spanning over 50 countries with permanent employees.

Powered by the latest technologies in the industry, Clintec provides flexible access to their global platform for clinical trial execution. This value proposition equips their clients with the ability to conduct the most complex of international clinical development programs without the fixed-cost and oversight burden of utilizing their own resources and technology.

Dr. Rabinder Buttar, founder and CEO of Clintec, said, “We are honored to have received the Queen¹s Award for Enterprise again as we celebrate 20 years of global success in clinical research. The people of Clintec are very excited and energized to grow the business further and continue to deliver excellent clinical research solutions to our clients, several of whom have partnered with us for many years.”

Dr. Buttar added, “The United Kingdom has served as a great base from which we have expanded into over 50 countries and we would like to thank all people in the UK and worldwide who have supported us along our incredible journey.”

Clintec’s extensive global reach throughout Western Europe, Central and Eastern Europe, Middle East and North Africa, Sub-Saharan Africa, Asia Pacific and North America, provides access to both developed and emerging markets, and all to the global clinical and ethical standards required for high-quality drug development.

Clintec specializes in clinical research solutions and functional service provision across phases I-IV in drug development with particular expertise in oncology and rare diseases. The company is developing innovative best-in-class treatments within the immuno-oncology space, to assist patients with various forms of cancer to obtain new and much needed therapies. The company partners with many of the world¹s global pharmaceutical companies, as well as smaller biotechnology companies, to fast-track their product development using innovative and flexible outsourcing solutions underpinned with an entrepreneurial and client-centric approach.

The award will be bestowed upon Clintec by Her Majesty The Queen on the advice of the Prime Minister.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing